Further subgroup propensity score - matched analysis indicated that , compared with use of other antihypertensive drugs , ACEI / ARB was also associated with decreased mortality ( adjusted hazard ratio , 0 . 30 [ 95 % CI , 0 . 12 - 0 . 70 ] ; P = 0 . 01 ) in patients with COVID - 19 and coexisting hypertension .